SBIR/STTR Research Award

Protein Overlays for Phosphoinositide Detection

Award identifier 5e16f6fe3dbe1fc0d6e4cf809f1bb56c795e8487f5f529ce5bdf13276272dc3fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ECHELON BIOSCIENCES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
EDK8FFD24SC4
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Phosphoinositides (PIPns), e.g., phosphatidylinositol 4,5-bisphosphate (PI 4,5) P2) are key signaling molecules in cellular communication. Specific PIPns recruit target signaling proteins and intracellular adapter proteins to inner membrane sites to activate protein kinases and thereby initiate signal transduction cascades in order to regulate exo- and endocytosis, protein sorting, cell proliferation and migration, tumorigenesis, apoptosis, and the control of cell shape. Determining the selectivity of a given target protein for a specific PIPn has become an important issue in deciphering downstream effectors and in new drug discovery efforts for potential therapeutics that could control protein-PIPn interactions. We propose to develop both components of an efficient protein overlay system that allows determining lipid selectivity of a known protein or levels of a given PIPn produced by lipid kinase and phosphatase reactions. Both methods use the same principle, i.e., detection of proteins bound to PIPns immobilized on nitrocellulose. First, we will optimize the lipid blot method, which we call "PIP-Strips (TM)." Second, we will develop highly selective, high-affinity proteins that recognize a specific PIPn using two coupled pleckstrin homology (PH) or FYVE domains; this new strategy is called Double PH(tm). The reagents prepared and optimized in this Phase I project will be used in Phase II to develop a variety of high throughput screening methods, e.g., rapid, automated assays for PIPn kinases and phosphatase and screening for small molecule inhibitors of protein-PIPn binding PROPOSED COMMERCIAL APPLICATION: A number of commercial applications have been envisioned for the products developed in this grant. PIP-Strips(TM) will be primarily sold as tools to determine lipid binding specificity of isolated proteins, their original purpose. Other applications include antibody screening and in house quality control of cloned proteins. Lipo-PIP-Strips(TM) will also fill these same roles. The Double-PH reagents will be sold as individual items targeted to a specific lipid and a kits focussing on a class of lipids such as 3'-phosphorylated PIPns.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

40 SBIR/STTR records share this UEI (1998–2024). Reported award amounts total $11,763,634. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.